Rothschild Investment LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-170
| Closed | -$517 | – | 3118 |
|
|
2024
Q4 | $517 | Sell |
170
-75
| -31% | -$228 | ﹤0.01% | 2523 |
|
|
2024
Q3 | $1.27K | Buy |
245
+175
| +250% | +$909 | ﹤0.01% | 1991 |
|
|
2024
Q2 | $180 | Hold |
70
| – | – | ﹤0.01% | 2524 |
|
|
2024
Q1 | $344 | Hold |
70
| – | – | ﹤0.01% | 1500 |
|
|
2023
Q4 | $615 | Buy |
+70
| New | +$615 | ﹤0.01% | 1218 |
|